Detalhe da pesquisa
1.
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.
Cancer
; 128(15): 2949-2957, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593736
2.
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol.
BMC Pediatr
; 19(1): 31, 2019 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684955
3.
[Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)].
Gan To Kagaku Ryoho
; 46(11): 1715-1719, 2019 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-31748480
4.
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial).
Medicine (Baltimore)
; 99(32): e21457, 2020 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32769873